Park Place Capital Corp

Position in ABBV — AbbVie Inc.

CIK 1965810 Homewood, AL

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,600,212

+$1,365,720 QoQ

Shares Held

14,307

+39.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

#1,528

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Healthcare · as of Jun 30, 2026

Park Place Capital Corp holds $11,539,581 across 14 Drug Manufacturers - General names. ABBV ranks #1 (31.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	14,307	$3,600,212
2	BMY	Bristol Myers Squibb Co	61,611	$3,550,025
3	LLY	ELI LILLY & Co	806	$966,740
4	MRK	Merck & Co., Inc.	6,461	$830,237
5	PFE	Pfizer Inc	30,792	$741,471
6	SNY	Sanofi	13,474	$574,800
7	JNJ	Johnson & Johnson	2,250	$571,432
8	AMGN	Amgen Inc	1,208	$437,440

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,600,212	14,307	+39.3%	Shares	Sole	2026-08-14
2026-03-31	$2,234,492	10,274	+89.6%	Shares	Sole	2026-04-09
2025-12-31	$1,238,187	5,419	-9.7%	Shares	Sole	2026-01-09
2025-09-30	$1,389,934	6,003	+0.2%	Shares	Sole	2025-10-22
2025-06-30	$1,112,420	5,993	-35.6%	Shares	Sole	2025-07-17
2025-03-31	$1,948,536	9,300	-17.1%	Shares	Sole	2025-04-24
2024-12-31	$1,992,727	11,214	+5.7%	Shares	Sole	2025-01-17
2024-09-30	$2,095,065	10,609	-12.2%	Shares	Sole	2024-10-08
2024-06-30	$2,071,961	12,080	-14.3%	Shares	Sole	2024-07-02
2024-03-31	$2,567,974	14,102	-23.5%	Shares	Sole	2024-04-18
2023-12-31	$2,856,716	18,434	+5.6%	Shares	Sole	2024-01-24
2023-09-30	$2,601,842	17,455	+4.4%	Shares	Sole	2023-10-17
2023-06-30	$2,252,820	16,721	-11.7%	Shares	Sole	2023-08-04
2023-03-31	$3,017,511	18,934	+2.8%	Shares	Sole	2023-05-02
2022-12-31	$2,977,825	18,426	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.